Issue: May 10, 2022

Read more

April 05, 2022
1 min read
Save

Genitourinary oncologist appointed deputy director of Fox Chase Cancer Center

Issue: May 10, 2022
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Elizabeth Plimack, MD, MS, chief of the division of genitourinary medical oncology at Fox Chase Cancer Center, has been appointed the center’s deputy director.

In this newly created role, Plimack’s focus areas will include programmatic scientific strategy, as well as development of institutional diversity, equity and inclusion initiatives. She also will further develop the Fox Chase bladder cancer program.

Elizabeth Plimack, MD, MS
Elizabeth Plimack

“Conducting world-class cancer science is an integral part of our Fox Chase mission and identity as [an NCI-designated] Comprehensive Cancer Center. Strong leadership in this area is critical to supporting our research enterprise and to promoting progress and success. That’s why I am so pleased to announce the appointment of Dr. Plimack to this key position,” Jonathan Chernoff, MD, PhD, cancer center director at Fox Chase, said in a press release. “Dr. Plimack’s work ethic, dedication to excellence, and clinical expertise will serve us all well as she assumes her vital new role.”

Plimack also serves as professor in the department of hematology/oncology and director of genitourinary clinical research at Fox Chase. She joined the institution in 2008.

She is recognized for her expertise in bladder cancer and kidney cancer.